197 related articles for article (PubMed ID: 23357778)
1. A novel mechanism underlies the hepatotoxicity of pyrazinamide.
Shih TY; Pai CY; Yang P; Chang WL; Wang NC; Hu OY
Antimicrob Agents Chemother; 2013 Apr; 57(4):1685-90. PubMed ID: 23357778
[TBL] [Abstract][Full Text] [Related]
2. Pyrazinamide-induced hepatotoxicity is alleviated by 4-PBA via inhibition of the PERK-eIF2α-ATF4-CHOP pathway.
Guo HL; Hassan HM; Ding PP; Wang SJ; Chen X; Wang T; Sun LX; Zhang LY; Jiang ZZ
Toxicology; 2017 Mar; 378():65-75. PubMed ID: 28063906
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling reveals potential key pathways involved in pyrazinamide-mediated hepatotoxicity in Wistar rats.
Zhang Y; Jiang Z; Su Y; Chen M; Li F; Liu L; Sun L; Wang Y; Zhang S; Zhang L
J Appl Toxicol; 2013 Aug; 33(8):807-19. PubMed ID: 22431067
[TBL] [Abstract][Full Text] [Related]
4. Liver Fatty Acid Binding Protein Deficiency Provokes Oxidative Stress, Inflammation, and Apoptosis-Mediated Hepatotoxicity Induced by Pyrazinamide in Zebrafish Larvae.
Zhang Y; Liu K; Hassan HM; Guo H; Ding P; Han L; He Q; Chen W; Hsiao CD; Zhang L; Jiang Z
Antimicrob Agents Chemother; 2016 Dec; 60(12):7347-7356. PubMed ID: 27697757
[TBL] [Abstract][Full Text] [Related]
5. Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cells.
Tostmann A; Aarnoutse RE; Peters WH; Richard PN; Boeree MJ
Drug Chem Toxicol; 2010 Jul; 33(3):325-8. PubMed ID: 20429806
[TBL] [Abstract][Full Text] [Related]
6. Pyrazinamide Induced Rat Cholestatic Liver Injury through Inhibition of FXR Regulatory Effect on Bile Acid Synthesis and Transport.
Guo HL; Hassan HM; Zhang Y; Dong SZ; Ding PP; Wang T; Sun LX; Zhang LY; Jiang ZZ
Toxicol Sci; 2016 Aug; 152(2):417-28. PubMed ID: 27255380
[TBL] [Abstract][Full Text] [Related]
7. Determination of pyrazinamide and its main metabolites in rat urine by high-performance liquid chromatography.
Mehmedagic A; Vérité P; Ménager S; Tharasse C; Chabenat C; André D; Lafont O
J Chromatogr B Biomed Sci Appl; 1997 Aug; 695(2):365-72. PubMed ID: 9300873
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
Jeong I; Park JS; Cho YJ; Yoon HI; Song J; Lee CT; Lee JH
J Korean Med Sci; 2015 Feb; 30(2):167-72. PubMed ID: 25653488
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the effects of concomitant caffeine administration on the metabolic disposition of pyrazinamide in rats.
Mehmedagic A; Verite P; Menager S; Tharasse C; Chabenat C; Andre D; Lafont O
Biopharm Drug Dispos; 2002 Jul; 23(5):191-5. PubMed ID: 12116050
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and Hepatotoxicity of Pyrazinamide, an Antituberculosis Drug.
Hussain Z; Zhu J; Ma X
Drug Metab Dispos; 2021 Aug; 49(8):679-682. PubMed ID: 34074731
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant and hepatoprotective activity of Fagonia schweinfurthii (Hadidi) Hadidi extract in carbon tetrachloride induced hepatotoxicity in HepG2 cell line and rats.
Pareek A; Godavarthi A; Issarani R; Nagori BP
J Ethnopharmacol; 2013 Dec; 150(3):973-81. PubMed ID: 24140589
[TBL] [Abstract][Full Text] [Related]
12. Pyrazinamide induced hepatic injury in rats through inhibiting the PPARα pathway.
Zhang Y; Guo H; Hassan HM; Ding PP; Su Y; Song Y; Wang T; Sun L; Zhang L; Jiang Z
J Appl Toxicol; 2016 Dec; 36(12):1579-1590. PubMed ID: 27071702
[TBL] [Abstract][Full Text] [Related]
13. Coadministration of Allopurinol To Increase Antimycobacterial Efficacy of Pyrazinamide as Evaluated in a Whole-Blood Bactericidal Activity Model.
Naftalin CM; Verma R; Gurumurthy M; Lu Q; Zimmerman M; Yeo BCM; Tan KH; Lin W; Yu B; Dartois V; Paton NI
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739782
[TBL] [Abstract][Full Text] [Related]
14. Effect of silibinin on the pharmacokinetics of pyrazinamide and pyrazinoic acid in rats.
Wu JW; Tsai TH
Drug Metab Dispos; 2007 Sep; 35(9):1603-10. PubMed ID: 17540707
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics approach discriminates toxicity index of pyrazinamide and its metabolic products, pyrazinoic acid and 5-hydroxy pyrazinoic acid.
Rawat A; Chaturvedi S; Singh AK; Guleria A; Dubey D; Keshari AK; Raj V; Rai A; Prakash A; Kumar U; Kumar D; Saha S
Hum Exp Toxicol; 2018 Apr; 37(4):373-389. PubMed ID: 28425350
[TBL] [Abstract][Full Text] [Related]
16. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
[TBL] [Abstract][Full Text] [Related]
17. The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis.
Kwon BS; Kim Y; Lee SH; Lim SY; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH
PLoS One; 2020; 15(7):e0236109. PubMed ID: 32692774
[TBL] [Abstract][Full Text] [Related]
18. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide.
Zhang Y; Scorpio A; Nikaido H; Sun Z
J Bacteriol; 1999 Apr; 181(7):2044-9. PubMed ID: 10094680
[TBL] [Abstract][Full Text] [Related]
19. Introducing RpsA Point Mutations Δ438A and D123A into the Chromosome of Mycobacterium tuberculosis Confirms Their Role in Causing Resistance to Pyrazinamide.
Shi W; Cui P; Niu H; Zhang S; Tønjum T; Zhu B; Zhang Y
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30858213
[TBL] [Abstract][Full Text] [Related]
20. Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
Rosen BC; Dillon NA; Peterson ND; Minato Y; Baughn AD
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
